Cleveland cardio company attracts $250K investment

Nonprofit venture development organization JumpStart will invest $250,000 in Guided Interventions, a startup company developing a product to help cardiologists better assess the physiological impact of coronary artery blockages.

Guided Interventions’ novel fractional flow reserve (FFR) guidewire provides an easier, more effective and more affordable way to obtain FFR measurements during coronary catheterization procedures.

Guided Interventions plans to use the JumpStart investment to complete development and test an initial prototype in relevant animal models. The company also intends to launch and scale its operations in Northeast Ohio within calendar year 2013, especially by hiring engineers. More details on the company and their product here.

Recent Posts

Blog Post Archive

Blog Post Categories

Search the Blog

Newsticker


BioOhio Member Mark BioOhio Member

Thermalin Diabetes raises $5.9M to support development of highly concentrated, rapid-acting insulin | MedCity News, July 29, 2014

CWRU summer biomedical program, in 13th year, transforms high school students into scientists | Cleveland.com, July 28, 2014

Cleveland helping to power a growing Midwest bioscience industry, study shows | Cleveland.com, July 28, 2014

Why Abbott Labs’ Tipp City plant is a bigger deal than you probably realize | Dayton Business Journal, July 25, 2014

AtriCure shares leaped in early trading after posting quarterly results that beat analysts’ expectations | Cincinnati Business Journal, July 25, 2014

Dee Ellingwood, former senior VP at Cincinnati Children’s Hospital Medical Center, joins Meridian Bioscience board of directors | Cincinnati Business Courier, July 25, 2014

University of Cincinnati President Santa Ono keeping busy during summer | Cincinnati Business Courier, July 25, 2014

Lab Chat: Discussing personalized treatments for cancer with Cleveland Clinic’s Dr. Mohamed Abazeed | Fresh Water Cleveland, July 24, 2014

ChanTest announces newly validated and re-engineered cells, expands portfolio of ion channel and GPCR cell lines | PR Web, July 24, 2014

OsteoSymbionics, makers of facial reconstruction products, profiled in Fresh Water Cleveland | Fresh Water Cleveland, July 24, 2014

Advanced Biological Marketing to expand production facility in Van Wert | Toledo Blade, July 24, 2014

CTI Clinical Trial and Consulting Services promotes two and adds six to their team | Cincinnati.com, July 24, 2014

Dayton Children’s Hospital featured in 2014 Google economic impact study for use of Google to attract new patients, inform, educate families | , July 24, 2014

Center for Disruptive Musculoskeletal Innovations formed by the NSF, UC San Francisco and Univeristy of Toledo | UCSF, July 24, 2014

Ohio State University’s Wexner Medical Center performs its 400th heart transplant | Columbus Dispatch, July 23, 2014

Akron Children’s Hospital leading research to standardize and improve safety for patient transfers | Columbus CEO, July 23, 2014

Juventas Therapeutics strengthens leadership team by adding two industry veterans as CFO and CSO | PR Newswire, July 23, 2014

Akron Children’s Hospital to broadcast “Bridging the Gap in Concussion Treatment” training event | Ohio.com, July 23, 2014

LabTV to work with The Ohio State University’s research scientists | WebWire, July 23, 2014

Cincinnati based CTI Clinical Trial and Consulting Services opens office in Sao Paulo, Brazil | Cincinnati.com, July 22, 2014